"Fighting for women's health, that to me seems like a legacy worth leaving."@halleberry, actress and founder of Respin, joined Editor @mcgrathmag to share why she started Respin and began advocating for women's menopausal health. #ForbesOver50https://t.co/MohoWgRgcV https://t.co/itl7bJoUqo ...

[Applause] This is Lexi. She's dying. The year is 2008 in Massachusetts, USA.When Lex was 15, she started experiencing terrible pain and profused bleeding during her periods. For 10 years, she consulted these symptoms with three pediatricians, an oncologist, a gastrologist, two family doctors and four gynecologists. All those experts only ever prescribed her birth control pills, which to no great surprise by both did not work.The only diagnosis Jesse received at the time was heavy menstrual bleeding. It was ...

"Fighting for women's health, that to me seems like a legacy worth leaving."@halleberry, actress and founder of Respin, shared why she started Respin and began advocating for women's menopausal health. #ForbesOver50https://t.co/lkKsOHoG0p https://t.co/TnfTCYe8tM ...

"Fighting for women's health, that to me seems like a legacy worth leaving."@halleberry, actress and founder of Respin, shared why she started Respin and began advocating for women's menopausal health. #ForbesOver50https://t.co/lkKsOHoG0p https://t.co/0q3nFbZIil ...

"Fighting for women's health, that to me seems like a legacy worth leaving."@halleberry, actress and founder of Respin, shared why she started Respin and began advocating for women's menopausal health. #ForbesOver50https://t.co/lkKsOHoG0p https://t.co/iMG1SlfZIu ...

"Fighting for women's health, that to me seems like a legacy worth leaving."@halleberry, actress and founder of Respin, shared why she started Respin and began advocating for women's menopausal health. #ForbesOver50https://t.co/lkKsOHoG0p https://t.co/mIalLiWrqD ...

"Fighting for women's health, that to me seems like a legacy worth leaving."Halle Berry, actress and founder of Respin, shared why she started Respin and began advocating for women's menopausal health. #ForbesOver50https://t.co/lkKsOHoG0p https://t.co/tG37ycroDd ...

Core Insights - WeightWatchers has successfully completed its strategic reorganization, enhancing its financial flexibility and accelerating its transformation with key leadership appointments and product milestones [1][2] - The company is launching an integrated women's health initiative focused on perimenopause and menopause, combining medical, nutritional, lifestyle, and community support [1][6] Leadership Changes - Dr. Kim Boyd has been appointed as Chief Medical Officer to lead the clinical strategy and program innovation, focusing on integrating emerging science into holistic solutions for members [3][4] - Uta Knablein has been appointed as Chief Product Officer to drive product strategy across the expanding weight health platform, bringing over two decades of experience in digital transformation and consumer-centric product development [9] Women's Health Initiative - WeightWatchers will introduce a new program later this year to support women through perimenopause, menopause, and postmenopause, offering tailored nutritional and behavioral strategies along with specialized clinical care [6][7] - The initiative aims to address a significant gap in healthcare for menopause, leveraging the company's existing strengths to deliver sustainable weight loss results [7][8] Board of Directors - A new Board of Directors has been established to guide the company through its next growth phase, including experienced leaders from various sectors such as healthcare and consumer platforms [11][12] - Notable appointments include Mike Mason, former President of Eli Lilly's Diabetes and Obesity business, who will contribute to the company's strategic direction in obesity care [12][13] Company Overview - WeightWatchers is recognized as the global leader in science-backed weight management, with over 60 years of experience and a holistic approach that combines clinical interventions, medications, and community support [16]

Industry Overview & Problem Statement - The silence around perimenopause is a public health crisis with global consequences [4] - Women between 35 and 55 are the forgotten generation in healthcare, with perimenopause impacting them during their prime [5] - By 2030, 1200 million (1.2 billion) women worldwide will be in menopause, and 75% will experience disruptive symptoms [6] - Despite the American Heart Association recognizing menopause as a critical risk factor for heart disease in women in 2020, little action has been taken [7] Economic Impact - The US economy loses $18 million (1.8% billion) annually due to lost workdays related to menopause [9] - One in four women consider leaving their job because of untreated menopause symptoms [8] - Menopause is not just a women's health issue, but also an economic, societal, and leadership issue [14] Healthcare System & Solutions - Menopause is barely a footnote in medical education, leading to misdiagnosis and inadequate care [12] - Women often face dismissive attitudes and inadequate treatment from healthcare providers [3][12] - Medical schools should make menopause education mandatory, business leaders should create supportive workplace policies, and policymakers should advocate for women's health [15]

Core Points - Daré Bioscience, Inc. convened its 2025 annual meeting of stockholders but adjourned it due to a lack of quorum, with plans to reconvene on July 9, 2025 [1][2] - Stockholders who have already submitted proxies or voted do not need to vote again, as their submissions will remain valid [3] - The company emphasizes the importance of voting for stockholders who have not yet participated, providing instructions for online and telephone voting [4] Company Overview - Daré Bioscience is a biopharmaceutical company focused on women's health, aiming to address unmet needs through innovative solutions [8] - The company has developed products such as XACIATO™, a vaginal gel for bacterial vaginosis, and is working on other candidates like Ovaprene® and Sildenafil Cream for various women's health issues [9][10] - Daré's leadership has received recognition for contributions to innovation and advocacy in women's health [11]